Sanofi signs EUR 300 million China healthcare collaboration

Paris-headquartered pharmaceutical company Sanofi has entered into a partnership with Hong Kong Stock Exchange-listed Chinese biopharmaceutical manufacturer Innovent Biologics.

Related Keywords

China ,United States ,Hong Kong ,United Kingdom ,Chinese ,Innovent Biologics ,Smith Anderson ,Herbert Smith Freehills ,John Reed ,Squire Patton Boggs ,Jaime Fong ,Jeremy Shen ,Michael Yu ,Robert Li ,Catalyst Clinical Research ,Hong Kong Stock Exc ,Hong Kong Stock Exchange Listed Chinese ,Smith Freehills ,May Bird ,Aptus Clinical ,